APP and Alzheimer disease: Two months following the injection of PS19BE into APP/PS1 mice (Fig. 1), we observed clusters of AT8+ tau particles surrounding 6E10+ Aβ plaques (Fig. 2a, b), resembling NP tau in AD patients.